Vitrolife AB (publ) (LON:0YAY)

London flag London · Delayed Price · Currency is GBP · Price in SEK
141.70
+2.14 (1.53%)
At close: Dec 5, 2025
-36.34%
Market Cap1.52B
Revenue (ttm)276.88M
Net Income (ttm)34.74M
Shares Outn/a
EPS (ttm)0.26
PE Ratio43.89
Forward PE31.80
Dividend0.09 (0.06%)
Ex-Dividend DateApr 30, 2025
Volume4,081
Average Volume24,996
Open139.75
Previous Close139.56
Day's Range141.00 - 142.90
52-Week Range126.10 - 300.00
Beta2.19
RSI46.51
Earnings DateFeb 3, 2026

About Vitrolife AB

Vitrolife AB (publ) provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas. It offers sperm processing, oocyte retrieval needles, micromanipulation pipettes, time-lapse systems, and evaluation tools, laser and imaging systems, IVF media and oil, embryo transfer, cryopreservation, and genomics kits. The company also provides eWitness and Labware products, such as dishes, pipettes, tubes, and VitroTemp. Vitrolife AB (publ) was incorporated in 1989 and is based in Gothenburg, Sweden. [Read more]

Sector Healthcare
Founded 1989
Employees 1,169
Stock Exchange London Stock Exchange
Ticker Symbol 0YAY
Full Company Profile

Financial Performance

Financial numbers in SEK Financial Statements

News

There is no news available yet.